JP2023526053A5 - - Google Patents
Info
- Publication number
- JP2023526053A5 JP2023526053A5 JP2022568815A JP2022568815A JP2023526053A5 JP 2023526053 A5 JP2023526053 A5 JP 2023526053A5 JP 2022568815 A JP2022568815 A JP 2022568815A JP 2022568815 A JP2022568815 A JP 2022568815A JP 2023526053 A5 JP2023526053 A5 JP 2023526053A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- construct according
- mir
- acid sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063024468P | 2020-05-13 | 2020-05-13 | |
| US63/024,468 | 2020-05-13 | ||
| US202163152835P | 2021-02-23 | 2021-02-23 | |
| US63/152,835 | 2021-02-23 | ||
| PCT/US2021/032354 WO2021231808A2 (en) | 2020-05-13 | 2021-05-13 | Compositions and methods for treating gjb2-associated hearing loss |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023526053A JP2023526053A (ja) | 2023-06-20 |
| JP2023526053A5 true JP2023526053A5 (https=) | 2024-05-23 |
Family
ID=78525016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568815A Pending JP2023526053A (ja) | 2020-05-13 | 2021-05-13 | Ｇｊｂ２関連難聴を処置するための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230183743A1 (https=) |
| EP (1) | EP4164695A4 (https=) |
| JP (1) | JP2023526053A (https=) |
| KR (1) | KR20230023641A (https=) |
| CN (1) | CN116096900A (https=) |
| AU (1) | AU2021270308A1 (https=) |
| CA (1) | CA3178197A1 (https=) |
| CL (1) | CL2022003147A1 (https=) |
| IL (1) | IL298091A (https=) |
| MX (1) | MX2022014085A (https=) |
| WO (1) | WO2021231808A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3727468A4 (en) | 2017-12-19 | 2021-09-22 | Akouos, Inc. | AAV-MEDIATED THERAPEUTIC ANTIBODIES DELIVERY TO THE INTERNAL EAR |
| TW202227476A (zh) * | 2020-09-14 | 2022-07-16 | 哈佛大學校長及研究員協會 | 編碼GJB2之重組腺相關病毒(rAAV)及其用途 |
| US20230340038A1 (en) * | 2020-09-14 | 2023-10-26 | President And Fellows Of Harvard College | Recombinant adeno associated virus (raav) encoding gjb2 and uses thereof |
| IL303317A (en) | 2020-12-01 | 2023-07-01 | Akouos Inc | ANTI-NATURAL ANTIBODY STRUCTURES AND RELATED METHODS FOR THE TREATMENT OF SYMPTOMS ASSOCIATED WITH VESTIBULAR SWANNOMA |
| MX2023013394A (es) * | 2021-05-13 | 2023-12-14 | Akouos Inc | Composiciones de suministro de terapia genica y metodos para tratar perdida auditiva. |
| CN115651932A (zh) * | 2021-12-10 | 2023-01-31 | 浙江理工大学 | 一种靶向消化道肿瘤双靶向溶瘤腺病毒的构建方法及其应用 |
| MX2024009520A (es) * | 2022-02-04 | 2024-09-11 | Decibel Therapeutics Inc | Elementos reguladores de gjb2 y usos de los mismos. |
| CN116836975A (zh) * | 2022-03-25 | 2023-10-03 | 上海玮美基因科技有限责任公司 | 一种耳蜗和/或前庭细胞特异性启动子及其应用 |
| CN119061007A (zh) * | 2023-06-02 | 2024-12-03 | 苏州星奥拓维生物技术有限公司 | 耳蜗支持细胞基因治疗和再生的方法 |
| CN117924458A (zh) * | 2024-01-26 | 2024-04-26 | 嘉兴元圣生物科技有限公司 | 一种获取果蝠connexin30蛋白编码cDNA序列、氨基酸序列的方法及其序列的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0173552B1 (en) * | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
| WO2005009287A2 (en) * | 2003-07-21 | 2005-02-03 | University Of Maryland, Baltimore | Drug delivery to the inner ear and methods of using same |
| US20150050354A1 (en) * | 2012-04-02 | 2015-02-19 | Moderna Therapeutics, Inc. | Modified polynucleotides for the treatment of otic diseases and conditions |
| HRP20180487T1 (hr) * | 2013-07-24 | 2018-05-04 | Commissariat à l'énergie atomique et aux énergies alternatives | Upotreba flekainida kao anti-koneksinskog sredstva i metoda za potenciranje učinaka psihotropnog lijeka |
| SG10201913266UA (en) * | 2015-12-11 | 2020-02-27 | Massachusetts Eye & Ear Infirmary | Materials and methods for delivering nucleic acids to cochlear and vestibular cells |
| WO2019200016A1 (en) * | 2018-04-10 | 2019-10-17 | President And Fellows Of Harvard College | Aav vectors encoding clarin-1 or gjb2 and uses thereof |
| WO2020077295A1 (en) * | 2018-10-11 | 2020-04-16 | Decibel Therapeutics, Inc. | Aav1 vectors and uses thereof for treatment of otic indications |
| EP4063510A1 (en) * | 2018-11-07 | 2022-09-28 | Akouos, Inc. | Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner ear |
| WO2021067448A1 (en) * | 2019-09-30 | 2021-04-08 | Applied Genetic Technologies Corporation | Adeno-associated virus (aav) systems for treatment of genetic hearing loss |
-
2021
- 2021-05-13 WO PCT/US2021/032354 patent/WO2021231808A2/en not_active Ceased
- 2021-05-13 MX MX2022014085A patent/MX2022014085A/es unknown
- 2021-05-13 US US17/998,486 patent/US20230183743A1/en active Pending
- 2021-05-13 JP JP2022568815A patent/JP2023526053A/ja active Pending
- 2021-05-13 IL IL298091A patent/IL298091A/en unknown
- 2021-05-13 EP EP21803692.9A patent/EP4164695A4/en active Pending
- 2021-05-13 AU AU2021270308A patent/AU2021270308A1/en active Pending
- 2021-05-13 KR KR1020227043071A patent/KR20230023641A/ko active Pending
- 2021-05-13 CN CN202180049197.6A patent/CN116096900A/zh active Pending
- 2021-05-13 CA CA3178197A patent/CA3178197A1/en active Pending
-
2022
- 2022-11-11 CL CL2022003147A patent/CL2022003147A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023526053A5 (https=) | ||
| ES2948902T3 (es) | Variantes de cápsides de virus adenoasociado y procedimientos de utilización de las mismas | |
| EP2940131B1 (en) | Aav variant | |
| JP2024038518A (ja) | 常染色体優性疾患のための遺伝子編集 | |
| JP6495273B2 (ja) | 変異ａａｖ、及び、細胞、臓器並びに組織への遺伝子導入のための組成物、方法並びに使用法 | |
| US20230183743A1 (en) | Compositions and methods for treating gjb2-associated hearing loss | |
| AU2020367437B2 (en) | Gene therapy for Alzheimer's disease | |
| US20250325696A1 (en) | Mutant of adeno-associated virus and use thereof | |
| EP3960755A1 (en) | Aav mutant having brain-targeting property | |
| JP2024521052A5 (https=) | ||
| WO2022240778A1 (en) | Gene therapy delivery compositions and methods for treating hearing loss | |
| WO2021021674A1 (en) | Methods of treating hearing loss using a secreted target protein | |
| US20250319201A1 (en) | Mutant of adeno-associated virus and use thereof | |
| WO2024240113A1 (zh) | 一种腺相关病毒衣壳蛋白、包含其的腺相关病毒、载体及应用 | |
| CN114848851A (zh) | 治疗β-地中海贫血的药物 | |
| CN115461465A (zh) | 用于AAV基因治疗的无CpG的ITR | |
| CN116656740A (zh) | 一种腺相关病毒基因治疗载体及其在制备治疗苯丙酮尿症的药物中的应用 | |
| WO2024079661A1 (en) | Atp7b gene therapy | |
| JP2021513871A (ja) | Ｆ８遺伝子機能を回復させるためのアデノ随伴ウイルス組成物及びその使用の方法 | |
| JP2024537775A5 (https=) | ||
| WO2025157262A1 (en) | Nucleic acids encoding follistatin and uses thereof | |
| US20260124322A1 (en) | Atp7b gene therapy | |
| WO2025137219A1 (en) | Compositions and methods for the treatment of disorders related to dystrophia myotonica protein kinase | |
| Fry | Development of CRISPR gene therapy for retinal degenerations | |
| TW202529776A (zh) | 新型肌肉特異性啟動子 |